Literature DB >> 20415851

99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: Caenorhabditis elegans as a model to study tissues involved in host immunity and microbial pathogenesis.

J E Irazoqui1, F M Ausubel.   

Abstract

The molecular mechanisms involved in host-microbe interactions during the initial stages of infection are poorly understood. The bacteria-eating nematode Caenorhabditis elegans provides an opportunity to dissect host-microbe interactions in the context of the whole organism, using powerful genomic, genetic and cell-biological tools. Because of the evolutionary conservation of ancient innate host defences and bacterial virulence mechanisms, studies in C. elegans hold great promise to shed light on defences in higher organisms, including mammals. Additionally, C. elegans pathogenesis models provide a platform for the identification of novel classes of anti-infective compounds with therapeutic value.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20415851      PMCID: PMC2841835          DOI: 10.1111/j.1365-2249.2010.04122.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  61 in total

1.  Shared transcriptional signature in Caenorhabditis elegans Dauer larvae and long-lived daf-2 mutants implicates detoxification system in longevity assurance.

Authors:  Joshua J McElwee; Eugene Schuster; Eric Blanc; James H Thomas; David Gems
Journal:  J Biol Chem       Date:  2004-08-11       Impact factor: 5.157

Review 2.  Invertebrates as a source of emerging human pathogens.

Authors:  Nicholas R Waterfield; Brendan W Wren; Richard H Ffrench-Constant
Journal:  Nat Rev Microbiol       Date:  2004-10       Impact factor: 60.633

Review 3.  Where will new antibiotics come from?

Authors:  Christopher Walsh
Journal:  Nat Rev Microbiol       Date:  2003-10       Impact factor: 60.633

4.  daf-16: An HNF-3/forkhead family member that can function to double the life-span of Caenorhabditis elegans.

Authors:  K Lin; J B Dorman; A Rodan; C Kenyon
Journal:  Science       Date:  1997-11-14       Impact factor: 47.728

5.  Pathogenic bacteria induce aversive olfactory learning in Caenorhabditis elegans.

Authors:  Yun Zhang; Hang Lu; Cornelia I Bargmann
Journal:  Nature       Date:  2005-11-10       Impact factor: 49.962

6.  The C. elegans Hox gene egl-5 is required for correct development of the hermaphrodite hindgut and for the response to rectal infection by Microbacterium nematophilum.

Authors:  Hannah R Nicholas; Jonathan Hodgkin
Journal:  Dev Biol       Date:  2009-02-13       Impact factor: 3.582

7.  High-throughput screen for novel antimicrobials using a whole animal infection model.

Authors:  Terence I Moy; Annie L Conery; Jonah Larkins-Ford; Gang Wu; Ralph Mazitschek; Gabriele Casadei; Kim Lewis; Anne E Carpenter; Frederick M Ausubel
Journal:  ACS Chem Biol       Date:  2009-07-17       Impact factor: 5.100

8.  Distinct innate immune responses to infection and wounding in the C. elegans epidermis.

Authors:  Nathalie Pujol; Sophie Cypowyj; Katja Ziegler; Anne Millet; Aline Astrain; Alexandr Goncharov; Yishi Jin; Andrew D Chisholm; Jonathan J Ewbank
Journal:  Curr Biol       Date:  2008-04-08       Impact factor: 10.834

9.  Anti-fungal innate immunity in C. elegans is enhanced by evolutionary diversification of antimicrobial peptides.

Authors:  Nathalie Pujol; Olivier Zugasti; Daniel Wong; Carole Couillault; C Léopold Kurz; Hinrich Schulenburg; Jonathan J Ewbank
Journal:  PLoS Pathog       Date:  2008-07-18       Impact factor: 6.823

10.  Microsporidia are natural intracellular parasites of the nematode Caenorhabditis elegans.

Authors:  Emily R Troemel; Marie-Anne Félix; Noah K Whiteman; Antoine Barrière; Frederick M Ausubel
Journal:  PLoS Biol       Date:  2008-12-09       Impact factor: 8.029

View more
  15 in total

1.  Using C. elegans for antimicrobial drug discovery.

Authors:  Athanasios Desalermos; Maged Muhammed; Justin Glavis-Bloom; Eleftherios Mylonakis
Journal:  Expert Opin Drug Discov       Date:  2011-06-01       Impact factor: 6.098

2.  Broadening the translational immunology landscape.

Authors:  M Peakman
Journal:  Clin Exp Immunol       Date:  2012-12       Impact factor: 4.330

3.  Model systems to the rescue: The relationship between aging and innate immunity.

Authors:  Scott Alper
Journal:  Commun Integr Biol       Date:  2010-09

4.  Competition and resilience between founder and introduced bacteria in the Caenorhabditis elegans gut.

Authors:  Cynthia Portal-Celhay; Martin J Blaser
Journal:  Infect Immun       Date:  2011-12-19       Impact factor: 3.441

Review 5.  Immune defense mechanisms in the Caenorhabditis elegans intestinal epithelium.

Authors:  Read Pukkila-Worley; Frederick M Ausubel
Journal:  Curr Opin Immunol       Date:  2012-01-09       Impact factor: 7.486

6.  99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: lifestyle changes affecting the host-environment interface.

Authors:  S Ehlers; S H E Kaufmann
Journal:  Clin Exp Immunol       Date:  2010-04       Impact factor: 4.330

7.  Comparative genomics RNAi screen identifies Eftud2 as a novel regulator of innate immunity.

Authors:  Lesly De Arras; Rebecca Laws; Sonia M Leach; Kyle Pontis; Jonathan H Freedman; David A Schwartz; Scott Alper
Journal:  Genetics       Date:  2013-12-20       Impact factor: 4.562

8.  An evolutionarily conserved innate immunity protein interaction network.

Authors:  Lesly De Arras; Amara Seng; Brad Lackford; Mohammad R Keikhaee; Bruce Bowerman; Jonathan H Freedman; David A Schwartz; Scott Alper
Journal:  J Biol Chem       Date:  2012-12-03       Impact factor: 5.157

Review 9.  Identifying novel spatiotemporal regulators of innate immunity.

Authors:  Francisco Victorino; Scott Alper
Journal:  Immunol Res       Date:  2013-03       Impact factor: 2.829

10.  A Stenotrophomonas maltophilia Strain Evades a Major Caenorhabditis elegans Defense Pathway.

Authors:  Corin V White; Brian J Darby; Robert J Breeden; Michael A Herman
Journal:  Infect Immun       Date:  2015-12-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.